Clinical Trial Update: Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2 clinical trial evaluated irinotecan with radiation therapy followed by chemotherapy for glioblastoma multiforme and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED